Annual Working Capital
$6.52 M
+$4.09 M+168.27%
December 31, 2023
Summary
- As of February 7, 2025, RSLS annual working capital is $6.52 million, with the most recent change of +$4.09 million (+168.27%) on December 31, 2023.
- During the last 3 years, RSLS annual working capital has risen by +$9.18 million (+344.98%).
- RSLS annual working capital is now -86.91% below its all-time high of $49.80 million, reached on December 31, 2007.
Performance
RSLS Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$1.31 M
-$1.57 M-54.50%
September 30, 2024
Summary
- As of February 7, 2025, RSLS quarterly working capital is $1.31 million, with the most recent change of -$1.57 million (-54.50%) on September 30, 2024.
- Over the past year, RSLS quarterly working capital has dropped by -$1.62 million (-55.19%).
- RSLS quarterly working capital is now -97.36% below its all-time high of $49.80 million, reached on December 31, 2007.
Performance
RSLS Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
RSLS Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +168.3% | -55.2% |
| 3 y3 years | +345.0% | -95.2% |
| 5 y5 years | +1731.2% | +121.5% |
RSLS Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -70.9% | +168.3% | -94.1% | at low |
| 5 y | 5-year | -70.9% | +345.0% | -95.2% | +109.8% |
| alltime | all time | -86.9% | +345.0% | -97.4% | +109.8% |
ReShape Lifesciences Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.31 M(-54.5%) |
| Jun 2024 | - | $2.89 M(-34.0%) |
| Mar 2024 | - | $4.38 M(-32.9%) |
| Dec 2023 | $6.52 M(+168.3%) | $6.52 M(+122.5%) |
| Sep 2023 | - | $2.93 M(-52.3%) |
| Jun 2023 | - | $6.14 M(-19.5%) |
| Mar 2023 | - | $7.63 M(+214.0%) |
| Dec 2022 | $2.43 M(-89.2%) | $2.43 M(-59.9%) |
| Sep 2022 | - | $6.06 M(-41.1%) |
| Jun 2022 | - | $10.30 M(-33.5%) |
| Mar 2022 | - | $15.48 M(-30.9%) |
| Dec 2021 | $22.41 M(-942.1%) | $22.41 M(-17.8%) |
| Sep 2021 | - | $27.25 M(+433.4%) |
| Jun 2021 | - | $5.11 M(-138.2%) |
| Mar 2021 | - | -$13.38 M(+402.9%) |
| Dec 2020 | -$2.66 M(+850.4%) | -$2.66 M(-56.5%) |
| Sep 2020 | - | -$6.12 M(+60.9%) |
| Jun 2020 | - | -$3.80 M(+68.6%) |
| Mar 2020 | - | -$2.25 M(+705.4%) |
| Dec 2019 | -$280.00 K(-178.7%) | -$280.00 K(-114.2%) |
| Sep 2019 | - | $1.97 M(+309.6%) |
| Jun 2019 | - | $480.00 K(-118.4%) |
| Mar 2019 | - | -$2.61 M(-833.7%) |
| Dec 2018 | $356.00 K(-94.8%) | $356.00 K(-105.8%) |
| Sep 2018 | - | -$6.17 M(+83.1%) |
| Jun 2018 | - | -$3.37 M(-2.6%) |
| Mar 2018 | - | -$3.46 M(-150.2%) |
| Dec 2017 | $6.89 M(+315.8%) | $6.89 M(-67.9%) |
| Sep 2017 | - | $21.47 M(+145.3%) |
| Jun 2017 | - | $8.75 M(-48.9%) |
| Mar 2017 | - | $17.14 M(+933.8%) |
| Dec 2016 | $1.66 M(-72.5%) | $1.66 M(+5.8%) |
| Sep 2016 | - | $1.57 M(-58.9%) |
| Jun 2016 | - | $3.82 M(-16.4%) |
| Mar 2016 | - | $4.57 M(-24.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2015 | $6.02 M(+13.5%) | $6.02 M(-41.1%) |
| Sep 2015 | - | $10.21 M(>+9900.0%) |
| Jun 2015 | - | $81.70 K(-98.6%) |
| Mar 2015 | - | $6.00 M(+13.2%) |
| Dec 2014 | $5.30 M(-67.2%) | $5.30 M(-41.1%) |
| Sep 2014 | - | $9.01 M(-36.2%) |
| Jun 2014 | - | $14.11 M(-20.4%) |
| Mar 2014 | - | $17.73 M(+9.8%) |
| Dec 2013 | $16.15 M(-4.2%) | $16.15 M(+9.8%) |
| Sep 2013 | - | $14.70 M(-13.6%) |
| Jun 2013 | - | $17.01 M(-25.2%) |
| Mar 2013 | - | $22.75 M(+34.9%) |
| Dec 2012 | $16.87 M(-23.3%) | $16.87 M(-27.8%) |
| Sep 2012 | - | $23.36 M(-5.6%) |
| Jun 2012 | - | $24.74 M(+32.5%) |
| Mar 2012 | - | $18.68 M(-15.1%) |
| Dec 2011 | $22.00 M(-34.9%) | $22.00 M(-26.8%) |
| Sep 2011 | - | $30.05 M(+27.1%) |
| Jun 2011 | - | $23.64 M(-18.2%) |
| Mar 2011 | - | $28.91 M(-14.5%) |
| Dec 2010 | $33.81 M(+283.2%) | $33.81 M(+287.1%) |
| Sep 2010 | - | $8.73 M(+29.2%) |
| Jun 2010 | - | $6.76 M(-20.6%) |
| Mar 2010 | - | $8.52 M(-3.4%) |
| Dec 2009 | $8.82 M(-57.8%) | $8.82 M(-45.9%) |
| Sep 2009 | - | $16.31 M(-34.4%) |
| Jun 2009 | - | $24.85 M(-14.8%) |
| Mar 2009 | - | $29.16 M(+39.4%) |
| Dec 2008 | $20.92 M(-58.0%) | $20.92 M(+9.2%) |
| Sep 2008 | - | $19.15 M(-35.5%) |
| Jun 2008 | - | $29.68 M(-27.8%) |
| Mar 2008 | - | $41.09 M(-17.5%) |
| Dec 2007 | $49.80 M(+66.4%) | $49.80 M(+204.5%) |
| Sep 2007 | - | $16.35 M(-45.3%) |
| Dec 2006 | $29.92 M(+246.3%) | $29.92 M(+246.3%) |
| Dec 2005 | $8.64 M | $8.64 M |
FAQ
- What is ReShape Lifesciences annual working capital?
- What is the all time high annual working capital for ReShape Lifesciences?
- What is ReShape Lifesciences annual working capital year-on-year change?
- What is ReShape Lifesciences quarterly working capital?
- What is the all time high quarterly working capital for ReShape Lifesciences?
- What is ReShape Lifesciences quarterly working capital year-on-year change?
What is ReShape Lifesciences annual working capital?
The current annual working capital of RSLS is $6.52 M
What is the all time high annual working capital for ReShape Lifesciences?
ReShape Lifesciences all-time high annual working capital is $49.80 M
What is ReShape Lifesciences annual working capital year-on-year change?
Over the past year, RSLS annual working capital has changed by +$4.09 M (+168.27%)
What is ReShape Lifesciences quarterly working capital?
The current quarterly working capital of RSLS is $1.31 M
What is the all time high quarterly working capital for ReShape Lifesciences?
ReShape Lifesciences all-time high quarterly working capital is $49.80 M
What is ReShape Lifesciences quarterly working capital year-on-year change?
Over the past year, RSLS quarterly working capital has changed by -$1.62 M (-55.19%)